"Salvax (Hydrating Topical Foam) is a great addition to our current portfolio of products based on Proderm Technology^TM," said Jeffrey S. Day, Quinnova's President & CEO. "When physicians are treating hyperkeratotic conditions, they can choose their product or active ingredient of choice - either Salvax (Hydrating Topical Foam) or Hydro 40^® Foam. Both products share the therapeutic and cosmetic benefits of Proderm Technology^TM while providing an active ingredient of the physician's preference (urea 40% or salicylic acid 6%)."

Salvax (Hydrating Topical Foam) differs from other topical salicylic acid 6% products (creams or lotions). First and foremost, Salvax (Hydrating Topical Foam) is more than a keratolytic agent which simply removes plaques, scales, and thickened dry skin. Due to the Proderm Technology^TM, Salvax (Hydrating Topical Foam) also addresses the underlying issues of a compromised skin barrier associated with hyperkeratotic conditions. It repairs and enhances the skin barrier function by replenishing lost lipids, thus resulting in a reduced trans-epidermal water loss (TEWL).

The water-lipid nature of the foam allows the foam ingredients to be rapidly absorbed and incorporated into the outer layers of the skin. Furthermore, the foam provides a cosmetically elegant feel in addition to ease of application because it is non-greasy and spreads easily, especially on hairy regions of the body where the foam does not tangle hair. Unlike some topical foam preparations, Proderm Technology^TM does not use either alcohol or other organic solvents, therefore it is well tolerated by patients.

The product features and benefits of Salvax (Hydrating Topical Foam) provide added value to treatment efficacy, patient tolerability, and convenience in use, thereby helping to increase compliance and maximized treatment results.

Quinnova Pharmaceuticals' sales force calls on dermatologists and podiatrists across the United States.

About Quinnova Pharmaceuticals, Inc.

Quinnova Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drug products based on innovative topical drug delivery platforms. For more information, please visit www.quinnova.com.